Delivery Order SPE2DR25D2205-SPE2DR26F1K76
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents under a firm fixed price contract valued at $4,489.92. The delivery order, issued on December 12, 2025, with an ultimate completion date of January 6, 2026, represents a non-competitive award to support federal medical supply needs. Performance will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents under a firm fixed price contract valued at $4,959.75. The delivery order, issued on December 19, 2025, is scheduled for ultimate completion by January 13, 2026, with performance to be executed at the contractor's facility in Conshohocken, Pennsylvania. This is a non-set-aside competitive award, reflecting AmerisourceBergen's established capability to meet...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents valued at $10,529.60 under a firm fixed price contract. This competitively awarded delivery order, with an ultimate completion date of September 30, 2025, represents a continuation of the vendor's ongoing pharmaceutical supply relationship with DLA. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $6,255.36 to supply Varivax vaccine with diluents. The contract, awarded on October 21, 2025, represents a firm fixed price delivery order with an ultimate completion date of November 12, 2025. This award was made on a competitive basis with no set-aside designation and reflects AmerisourceBergen's role as a critical pharmaceutical distributor supporting federal medical procurement needs. The place of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of Varivax vaccine with diluents, valued at $7,935.60 with a firm fixed price structure. The contract, which is classified as a child award under a larger indefinite delivery vehicle, has an ultimate completion date of January 6, 2026, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This award was made through open...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Varivax vaccine with diluents, valued at $4,997.30 with a firm fixed price structure. The contract is non-competitive and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion comprehensive pharmaceutical support vehicle running through December 2026. Performance will be...
- The Defense Logistics Agency awarded a $94,770.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Varivax vaccine with diluents. The contract, which is classified as a child delivery order under a larger indefinite delivery vehicle, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 19, 2025. This award was made through open competition with no set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $5,047.90 to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of Varivax vaccine with diluents. The contract is a firm fixed price delivery order with an ultimate completion date of December 17, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to...
- The Defense Logistics Agency awarded a $157,951.50 delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Varivax vaccine with diluents. This firm fixed-price, non-set-aside contract is scheduled for completion by November 10, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order supports the federal government's pharmaceutical supply chain requirements, particularly for military and veteran...
- The Defense Logistics Agency (DLA) awarded a $3,793.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents. The contract, issued on July 14, 2025, is scheduled for ultimate completion by August 4, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order was competitively awarded without any set-aside designation, demonstrating the contractor's capability to compete in open federal...
- SPE2DR25D2205Indefinite Delivery Contract
- SPE2DR25D2205-SPE2DR26F1K76Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents valued at $81,575.20 under a firm fixed-price contract. The delivery order, issued on November 26, 2025, is scheduled for completion by December 18, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. This award represents a non-competitive delivery order issued under a larger contract vehicle, demonstrating AmerisourceBergen's established capability to supply critical pharmaceutical products to the federal government's military and veteran healthcare systems. This delivery order is a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's selection as a prime vendor reflects its position as a major pharmaceutical distributor capable of fulfilling the federal government's vaccine procurement needs on a competitive basis across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $81.6k | 11/25/25 |